These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24225128)

  • 1. A potent soluble epoxide hydrolase inhibitor, t-AUCB, modulates cholesterol balance and oxidized low density lipoprotein metabolism in adipocytes in vitro.
    Shen L; Peng H; Zhao S; Xu D
    Biol Chem; 2014 Apr; 395(4):443-51. PubMed ID: 24225128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of soluble epoxide hydrolase in mice promotes reverse cholesterol transport and regression of atherosclerosis.
    Shen L; Peng H; Peng R; Fan Q; Zhao S; Xu D; Morisseau C; Chiamvimonvat N; Hammock BD
    Atherosclerosis; 2015 Apr; 239(2):557-65. PubMed ID: 25733327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of soluble epoxide hydrolase inhibitors on cholesterol efflux in adipocytes].
    Jiang Y; Xu DY; Zhao SP; Liu YW; Zhao TT; DU JQ
    Zhonghua Nei Ke Za Zhi; 2011 Mar; 50(3):235-9. PubMed ID: 21600089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of soluble epoxide hydrolase inhibitors on lipid metabolism and secretive functions of adipocytes].
    Jiang Y; Xu DY; Zhao TT; DU JQ; Peng DQ; Zhao SP
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(2):111-6. PubMed ID: 21418994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Soluble epoxide hydrolase inhibitor t-AUCB ameliorates ox-LDL induced conversion of macrophages into foam cells through activating the PPARγ-ABCA1 pathway].
    Zhao TT; Peng R; Shen L; Zhao X; Xu DY; Zhao SP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar; 40(3):248-52. PubMed ID: 22801272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.
    Xu DY; Davis BB; Wang ZH; Zhao SP; Wasti B; Liu ZL; Li N; Morisseau C; Chiamvimonvat N; Hammock BD
    Int J Cardiol; 2013 Aug; 167(4):1298-304. PubMed ID: 22525341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effects of oxidized low-density lipoprotein on LXR-ABCA1-apoA-I pathway in 3T3-L1 cells.
    Zhao SP; Yu BL; Xie XZ; Dong SZ; Dong J
    Int J Cardiol; 2008 Aug; 128(1):42-7. PubMed ID: 17643522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
    Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphatase activity of soluble epoxide hydrolase regulates ATP-binding cassette transporter-A1-dependent cholesterol efflux.
    Lien CC; Chen CH; Lee YM; Guo BC; Cheng LC; Pan CC; Shyue SK; Lee TS
    J Cell Mol Med; 2019 Oct; 23(10):6611-6621. PubMed ID: 31436906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
    Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
    Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-density lipoprotein increases the uptake of oxidized low density lipoprotein via PPARγ/CD36 pathway in inflammatory adipocytes.
    Zhong Q; Zhao S; Yu B; Wang X; Matyal R; Li Y; Jiang Z
    Int J Biol Sci; 2015; 11(3):256-65. PubMed ID: 25678844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.
    Roche C; Guerrot D; Harouki N; Duflot T; Besnier M; Rémy-Jouet I; Renet S; Dumesnil A; Lejeune A; Morisseau C; Richard V; Bellien J
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():148-54. PubMed ID: 26022136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced coronary reactive hyperemia in mice was reversed by the soluble epoxide hydrolase inhibitor (t-AUCB): Role of adenosine A
    Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Ledent C; Tilley SL; Nayeem MA
    Prostaglandins Other Lipid Mediat; 2017 Jul; 131():83-95. PubMed ID: 28890385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.
    Shaik JS; Ahmad M; Li W; Rose ME; Foley LM; Hitchens TK; Graham SH; Hwang SH; Hammock BD; Poloyac SM
    Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1605-13. PubMed ID: 24043255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of soluble epoxide hydrolase reprogram white fat to beige-like fat through an increase in mitochondrial integrity, HO-1-adiponectin in vitro and in vivo.
    Liu L; Puri N; Raffaele M; Schragenheim J; Singh SP; Bradbury JA; Bellner L; Vanella L; Zeldin DC; Cao J; Abraham NG
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():1-8. PubMed ID: 30041041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.
    Zhang W; Yang AL; Liao J; Li H; Dong H; Chung YT; Bai H; Matkowskyj KA; Hammock BD; Yang GY
    Dig Dis Sci; 2012 Oct; 57(10):2580-91. PubMed ID: 22588244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate enhances CD36 mediated endocytic uptake and degradation of oxidized low density lipoprotein in adipocytes from hypercholesterolemia rabbit.
    Zhao SP; Wu J; Zhang DQ; Ye HJ; Liu L; Li JQ
    Atherosclerosis; 2004 Dec; 177(2):255-62. PubMed ID: 15530897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of oxidized low-density lipoprotein on cholesterol efflux in 3T3-L1 cells].
    Yu BL; Zhao SP; Xie XZ; Dong SZ; Dong J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):631-6. PubMed ID: 17767055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
    Chaudhary KR; Abukhashim M; Hwang SH; Hammock BD; Seubert JM
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):67-73. PubMed ID: 19834332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model.
    Liu JY; Yang J; Inceoglu B; Qiu H; Ulu A; Hwang SH; Chiamvimonvat N; Hammock BD
    Biochem Pharmacol; 2010 Mar; 79(6):880-7. PubMed ID: 19896470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.